肝癌是严重威胁中国人民生命与健康的疾病。全球每年新增60~70万肝癌病人,其中约55%发生在我国,是影响我国人民生存的第二大肿瘤杀手,我国每年死于肝癌的病人30万左右;同时我国有庞大的肝癌危险人群,即近1亿名乙型肝炎病毒携带者,因此,肝癌的防治工作一直是我国医学界面临的重大课题。从20世纪50年代末至今,经过几代医务人员的不懈努力,肝癌的诊断和治疗水平都有了飞跃性发展。肝癌手术后5年生存率由 Liver cancer is a serious disease that threatens the life and health of Chinese people. About 60% to 70% of liver cancer patients are newly added every year in the world, about 55% of which occur in our country and are the second largest tumor killer affecting the survival of our people. About 300,000 patients die from liver cancer each year in our country. At the same time, , That is, nearly 100 million hepatitis B virus carriers, therefore, prevention and treatment of liver cancer has always been a major issue facing the medical community in our country. From the late 1950s until now, after several generations of medical staff’s unremitting efforts, the diagnosis and treatment of liver cancer have made leaps and bounds. 5-year survival rate after liver cancer surgery